Professor Wolfgang KoenigAdvisory Board
Professor Wolfgang Koenig
Professor Koenig, MD, PhD, FRCP, FESC, FACC, FAHA is a Professor of Cardiology at the Clinic for cardiovascular disease at the German Heart Center in Munich, at the Technical University of Munich. Until March 2015 he was Professor of Medicine/Cardiology at the University of Ulm Medical School, Ulm, Germany where he was the Director of the Preventive Cardiology Program and the Clinical Trial Unit (CTU) at the Department of Internal Medicine II – Cardiology of the University of Ulm Medical Center. He is a Board certified Internist and interventional cardiologist, and also specialized in Intensive Care Medicine. In addition he has extensive experience in the molecular epidemiology of cardiovascular diseases. He has held a number of different prestigious positions. He was a former Director of the WHO-MONICA Augsburg Myocardial Infarction Register, Deputy Director of the Departments of Medicine and Head of the Emergency Room, Director of the Intensive Care Unit, and Director of Cardiovascular Laboratories. Since joining the Deutsches Herzzentrum München, he has become an established investigator of the Munich Heart Alliance within the DZHK (German Centre for Cardiovascular Research). Presently he serves also on the Steering Committee of various large international randomized clinical trials testing innovative targets in cardiovascular medicine.
Dr. Koenig`s research interests involve the molecular basis of atherothrombogenesis including genetics with particular interest in the interrelations between hemostasis, inflammation, and atherothrombotic complications / type 2 diabetes, the metabolic syndrome, the clinical pharmacology of cardiovascular active compounds, and the clinical epidemiology of cardiovascular disorders, focusing on the identification and evaluation of novel biomarkers for cardiometabolic diseases.
Dr. Koenig has an impressive publication list including papers in first rank journals. He ranks number 6 of the most frequently cited German speaking researcher in cardiovascular disease between 2008 and 2012.
In 2014 he received the Rudolf Schönheimer Award from the German Atherosclerosis Society. He has been a member of the ERAB Advisory Board since it was founded in 2003.